Insufficient scRNA-seq data for expression of PRAG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 5881.65 | 653 / 653 | 99% | 41.66 | 596 / 605 |
breast | 100% | 2282.38 | 459 / 459 | 95% | 33.91 | 1067 / 1118 |
lung | 97% | 951.94 | 558 / 578 | 96% | 21.99 | 1110 / 1155 |
brain | 87% | 2525.55 | 2306 / 2642 | 99% | 19.35 | 701 / 705 |
kidney | 99% | 791.69 | 88 / 89 | 87% | 13.76 | 788 / 901 |
esophagus | 80% | 631.64 | 1159 / 1445 | 100% | 46.22 | 183 / 183 |
skin | 88% | 1210.80 | 1588 / 1809 | 92% | 30.60 | 436 / 472 |
stomach | 79% | 651.43 | 284 / 359 | 98% | 31.62 | 281 / 286 |
prostate | 88% | 605.63 | 216 / 245 | 86% | 10.85 | 431 / 502 |
ovary | 77% | 846.86 | 139 / 180 | 94% | 19.02 | 404 / 430 |
intestine | 67% | 1100.46 | 652 / 966 | 98% | 25.44 | 516 / 527 |
bladder | 71% | 365.76 | 15 / 21 | 92% | 17.53 | 465 / 504 |
pancreas | 66% | 408.38 | 216 / 328 | 97% | 24.24 | 172 / 178 |
uterus | 59% | 335.35 | 101 / 170 | 92% | 19.84 | 423 / 459 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.48 | 29 / 29 |
spleen | 100% | 1922.27 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.50 | 1 / 1 |
adipose | 99% | 1778.88 | 1195 / 1204 | 0% | 0 | 0 / 0 |
liver | 42% | 248.74 | 96 / 226 | 56% | 8.88 | 229 / 406 |
tonsil | 0% | 0 | 0 / 0 | 93% | 22.05 | 42 / 45 |
muscle | 89% | 599.07 | 714 / 803 | 0% | 0 | 0 / 0 |
heart | 73% | 507.73 | 626 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 48% | 672.79 | 442 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 22% | 96.01 | 58 / 258 | 21% | 2.26 | 49 / 230 |
eye | 0% | 0 | 0 / 0 | 44% | 3.99 | 35 / 80 |
blood vessel | 37% | 187.11 | 489 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008360 | Biological process | regulation of cell shape |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0016477 | Biological process | cell migration |
GO_2000145 | Biological process | regulation of cell motility |
GO_0005829 | Cellular component | cytosol |
GO_0005925 | Cellular component | focal adhesion |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | PRAG1 |
Protein name | Inactive tyrosine-protein kinase PRAG1 (PEAK1-related kinase-activating pseudokinase 1) (Pragmin) (Sugen kinase 223) (SgK223) |
Synonyms | SGK223 |
Description | FUNCTION: Catalytically inactive protein kinase that acts as a scaffold protein. Functions as an effector of the small GTPase RND2, which stimulates RhoA activity and inhibits NGF-induced neurite outgrowth (By similarity). Promotes Src family kinase (SFK) signaling by regulating the subcellular localization of CSK, a negative regulator of these kinases, leading to the regulation of cell morphology and motility by a CSK-dependent mechanism (By similarity). Acts as a critical coactivator of Notch signaling (By similarity). . |
Accessions | Q86YV5 ENST00000615670.5 |